Strategic Partnerships Koios Medical has multiple high-profile integration and distribution partners (Philips, SimonMed, RamSoft, iCAD) which creates ready-made collaboration and co-selling opportunities to expand market reach and accelerate adoption of Koios DS across imaging centers and hosptials.

FDA Cleared Advantage The FDA-cleared Koios DS offers a trusted clinical decision support layer in ultrasound, enabling near-term conversations with hospital radiology departments about validation, risk of malpractice exposure reduction, and workflow-enhanced diagnostic confidence.

Multi-Modality Synergy Recent partnerships that integrate Koios with breast imaging AI suites and multi-modality workflows (e.g., ProFound AI integration) indicate opportunities to upsell to centers pursuing end-to-end AI-assisted screening and faster lesion classification across breast and thyroid exams.

Growth Footprint With a growing install base in leading healthcare institutions and a revenue range in the tens of millions, Koios is positioned to target mid-to-large radiology groups and health systems seeking AI-enabled second opinions to improve diagnostic metrics and throughput.

Investment Readiness Recent funding activity and international interest (notably Mitsui/MBK involvement) alongside strategic buyers suggests potential for co-investment, channel financing, or large-scale procurement discussions to support nationwide or regional deployments.